Oncotelic Company banner

Oncotelic

Oncology

Overview


Oncotelic /Mateon is a convergent of PointR AI clustercomputing, Oncotelic antisense platform, and Mateon vascular disrupting agent. Lead asset OT-101 is an antisense against TGF-beta for cancer, covid-19, and other viruses


0 Job openings at Oncotelic

Connect With Us

Explore jobs at Oncotelic